Research in the field of medicine is somewhat an unending cycle of events as scientists, and medical practitioners are continuously trying to come up with better methods of treatment, which can suppress some of the major ailments that exist in the today’s society. Such a fact remains true for Multiple Sclerosis disease, where there might be some light at the end of the tunnel regarding finding its cure. The disease is caused by the failure of the immune system of patients to coordinate with the central nervous system adequately.
The National Institute of Allergy and Infectious Disease carried out a research that took close to 5 years, with a total of 69 participants experiencing multiple sclerosis, being involved in the process. Evidence from the research clearly indicates that inducing a High Dose Immunosuppressive Therapy, in conjunction with transplanting the patient’s stem cells, which are usually involved in blood cell formation, can help in reversing the adverse effects posed by Multiple Sclerosis on a patient.
One of the notable personalities at the center of uncovering the last and most suitable medication for the treatment of Multiple Sclerosis is Dr. Shival Gopal Vasishta. Having an extensive experience in the field of neurology that spans for over 38 years, Dr. Shival Gopal Vasishta is a professional who has worked tirelessly with other medical experts, at the Kennedy University Hospital to try to come up with the most suitable solution for countering the effects of Multiple Sclerosis.
Multiple Sclerosis, primarily affects the nervous system which eventually interferes with the vital functioning of the body such as morbidity. Having successfully completed postgraduate studies at the Boston City Hospital, Dr. Gopal Vasishta brings his extreme expertise to the table, so as to ensure that his patients end up receiving the best medical care leading to full recovery. Dr. Gopal Vasishta is a certified neurologist whose base of operation is in Voorhees, New Jersey. Furthermore, he is at the forefront in trying to ensure that the new methods of medication are satisfactory to the society as a whole.